​

Globus Medical (GMED) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GMED Stock Forecast

Globus Medical (GMED) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $104.00, with a high of $115.00 and a low of $64.00. This represents a 18.29% increase from the last price of $87.92.

$45 $59 $73 $87 $101 $115 High: $115 Avg: $104 Low: $64 Last Closed Price: $87.92

GMED Stock Rating

Globus Medical stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 27 Buy (75.00%), 8 Hold (22.22%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Buy
Total 36 1 8 27 Strong Sell Sell Hold Buy Strong Buy

GMED Price Target Upside V Benchmarks

TypeNameUpside
StockGlobus Medical18.29%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks35.61%

Price Target Trends

1M3M12M
# Anlaysts-59
Avg Price Target-$112.80$102.33
Last Closing Price$87.92$87.92$87.92
Upside/Downside-28.30%16.39%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26464--14
Mar, 26564--15
Feb, 26564--15
Jan, 26455--14
Dec, 25454--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 25, 2026Richard NewitterTruist Financial$115.00$94.3221.93%30.80%
Jan 30, 2026Needham$112.00$90.2224.14%27.39%
Jan 26, 2026Cowen & Co.$110.00$92.9818.31%25.11%
Jan 09, 2026Canaccord Genuity$112.00$94.6218.37%27.39%
Jan 08, 2026Matt O'BrienPiper Sandler$115.00$90.5427.02%30.80%
Dec 17, 2025Shagun SinghRBC Capital$100.00$85.7916.56%13.74%
Dec 17, 2025Caitlin CroninCanaccord Genuity$105.00$85.7922.39%19.43%
Oct 28, 2025Thomas StephanStifel Nicolaus$64.00$63.460.85%-27.21%
Oct 10, 2025RBC Capital$88.00$57.5552.91%0.09%
Dec 02, 2024Kallum TitchmarshMorgan Stanley$100.00$85.5216.93%13.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 30, 2026NeedhamHoldBuyupgrade
Jan 26, 2026Cowen & Co.Buyinitialise
Jan 08, 2026Piper SandlerOverweightOverweighthold
Jan 08, 2026CitigroupMarket PerformMarket Performhold
Dec 30, 2025BTIGNeutralNeutralhold
Dec 17, 2025RBC CapitalOutperformOutperformhold
Dec 02, 2025Morgan StanleyOverweightOverweighthold
Nov 07, 2025Bank of America SecuritiesUnderperformBuyupgrade
Jun 10, 2025BarclaysOverweightOverweighthold
Nov 06, 2024NeedhamHoldHoldhold

Financial Forecast

EPS Forecast

$0 $1 $2 $3 $4 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.48$1.89$1.09$0.76$3.98---
Avg Forecast$2.02$2.03$2.31$2.99$3.43$3.93$4.62$4.89
High Forecast$2.04$2.04$2.34$3.01$3.56$4.55$4.67$4.94
Low Forecast$2.00$2.02$2.28$2.92$3.24$3.13$4.58$4.84
Surprise %-26.73%-6.90%-52.81%-74.58%16.03%---

Revenue Forecast

$500M $1B $2B $2B $3B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$958.10M$1.02B$1.57B$2.52B$2.94B---
Avg Forecast$951.95M$1.02B$1.56B$2.51B$2.67B$2.85B$3.06B$3.32B
High Forecast$957.61M$1.03B$1.57B$2.53B$2.69B$2.85B$3.06B$3.35B
Low Forecast$944.84M$1.02B$1.55B$2.50B$2.66B$2.85B$3.05B$3.30B
Surprise %0.65%-0.20%0.59%0.51%10.01%---

Net Income Forecast

$50M $160M $270M $380M $490M $600M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$149.19M$190.17M$122.87M$102.98M$537.87M---
Avg Forecast$118.77M$156.07M$122.87M$339.44M$389.74M$466.32M$529.89M$560.54M
High Forecast$142.53M$187.28M$147.45M$344.61M$408.46M$521.58M$534.94M$565.80M
Low Forecast$95.02M$124.85M$98.30M$334.27M$371.02M$358.42M$524.83M$555.10M
Surprise %25.61%21.85%--69.66%38.01%---

GMED Forecast FAQ

Is Globus Medical stock a buy?

Globus Medical stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 27 Buy, 8 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Globus Medical is a favorable investment for most analysts.

What is Globus Medical's price target?

Globus Medical's price target, set by 36 Wall Street analysts, averages $104 over the next 12 months. The price target range spans from $64 at the low end to $115 at the high end, suggesting a potential 18.29% change from the previous closing price of $87.92.

How does Globus Medical stock forecast compare to its benchmarks?

Globus Medical's stock forecast shows a 18.29% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (35.61%).

What is the breakdown of analyst ratings for Globus Medical over the past three months?

  • April 2026: 28.57% Strong Buy, 42.86% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 33.33% Strong Buy, 40.00% Buy, 26.67% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 33.33% Strong Buy, 40.00% Buy, 26.67% Hold, 0% Sell, 0% Strong Sell.

What is Globus Medical’s EPS forecast?

Globus Medical's average annual EPS forecast for its fiscal year ending in December 2026 is $3.93, marking a -1.26% decrease from the reported $3.98 in 2025. Estimates for the following years are $4.62 in 2027, and $4.89 in 2028.

What is Globus Medical’s revenue forecast?

Globus Medical's average annual revenue forecast for its fiscal year ending in December 2026 is $2.85B, reflecting a -2.99% decrease from the reported $2.94B in 2025. The forecast for 2027 is $3.06B, and $3.32B for 2028.

What is Globus Medical’s net income forecast?

Globus Medical's net income forecast for the fiscal year ending in December 2026 stands at $466.32M, representing a -13.30% decrease from the reported $537.87M in 2025. Projections indicate $529.89M in 2027, and $560.54M in 2028.